This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Transition Therapeutics Inc (TTHI)

NASDAQ: Health Care

Company Balance Sheet
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Assets
Cash and Equivalents 53.63M 22.01M 12.75M 17.99M
Receivables 405.76K 206.52K 281.00K 541.14K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 56.93M 27.39M 19.30M 24.51M
Property, Plant & Equipment, Gross 148.96K 160.33K 211.53K 1.22M
Accumulated Depreciation & Depletion 0.00 0.00 0.00 805.30K
Property, Plant & Equipment, Net 148.96K 160.33K 211.53K 413.60K
Intangibles 7.51M 8.53M 16.99M 19.66M
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 7.65M 8.69M 17.20M 20.08M
Liabilities & Shareholder Equity
Total Assets 64.59M 36.08M 36.49M 44.58M
Accounts Payable 1.49M 834.09K 2.28M 976.09K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 2.21M 0.00 0.00
Total Current Liabilities 5.59M 3.05M 3.44M 976.09K
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 3.61M 1.37M 1.45M 47.21K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 3.61M 1.39M 1.45M 47.21K
Total Liabilities 9.20M 4.44M 4.89M 1.02M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 55.39M 31.64M 31.61M 43.56M
Common Par 0.00 157.79M 0.00 0.00
Additional Paid In Capital 208.22M 14.09M 175.62M 177.94M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -160.39M -142.49M -146.95M -137.26M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 7.56M 2.24M 2.93M 2.88M
Total Capitalization 55.39M 31.64M 31.61M 43.56M
Total Equity 55.39M 31.64M 31.61M 43.56M
Total Liabilities & Stock Equity 64.59M 36.08M 36.49M 44.58M
Total Common Shares Outstanding 35.30M 26.93M 26.92M 23.22M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 30.09M 26.84M 25.38M 23.14M
Diluted Weighted Shares Outstanding 30.09M 26.84M 25.38M 23.14M
Number of Employees 24 16 16 20
Number of Part-Time Employees 0 0 0 0
TTHI News

TTHI Transition Therapeutics Inc

Analysts Ratings for TTHI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET TTHI ANALYST REPORT

Brokerage Partners

TTHI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs